REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.495
Bid: 0.40
Ask: 0.59
Change: 0.00 (0.00%)
Spread: 0.19 (47.50%)
Open: 0.495
High: 0.00
Low: 0.00
Prev. Close: 0.495
EME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Option Purchase and Exercise

13 Mar 2017 10:30

RNS Number : 2649Z
Empyrean Energy PLC
13 March 2017
 

This announcement contains inside information

 

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

13 March 2017

Empyrean Energy PLC ('Empyrean' or 'the Company')

 

Option Purchase and Exercise

 

Empyrean confirms that it was notified that on 10 March 2017 that Apnea Holdings Pty Ltd ("Apnea"), a company which is wholly-owned by Tom Kelly, CEO of Empyrean, on that date purchased options (the "Options") in respect of 63,000,000 ordinary shares of 0.2p each in in the Company ("Ordinary Shares") from a third party not connected with the Company (the "Seller"). The terms of the Options are set out below and the total consideration payable by Apnea in respect of the purchase of the Options was AU$275,000 (equivalent to approximately £171,000).

 

Number of Options

Exercise Price

Expiry Date

18,000,000

0.2 pence

19 July 2017

15,000,000

2.1 pence

19 July 2017

15,000,000

4.1 pence

25 March 2018

15,000,000

2.1 pence

26 July 2019

 

Further to the announcement on 15 December 2016, the first tranche of Options detailed above reflects the agreement reached between the Company and the Seller that, if this tranche of Options were to be exercised prior to shareholder approval being granted for the necessary capitalisation from reserves to allow the exercise price to be amended to 0.1p, then this tranche of Options would have an exercise price of 0.2p and convert into a greater number of 18,000,000 Ordinary Shares.

 

Empyrean also announces that, on 10 March 2017, it received notice from Apnea that it intended to exercise its option in relation to 18,000,000 Ordinary Shares at an exercise price of 0.2 pence each. Accordingly, the Company has issued and allotted 18,000,000 Ordinary Shares (the "New Ordinary Shares"). Application will be made for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to take place on 17 March 2017. These New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

Following this exercise, Tom Kelly has a beneficial interest in 38,881,563 Ordinary Shares, representing 16.21% per cent. of the enlarged issued share capital of the Company.

 

Following the transaction, Empyrean's total issued share capital will comprise 239,833,853 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

**ENDS**

 

Empyrean Energy plc

Tom Kelly

Tel: +61 8 9481 0389

Cenkos Securities plc

Neil McDonald

Tel: +44 (0) 131 220 9771

Beth McKiernan

Tel: +44 (0) 131 220 9778

Nick Tulloch

Tel: +44 (0) 131 220 9772

St Brides Partners Ltd

Elisabeth Cowell

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

Tel: +44 (0) 20 7236 1177

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tom Kelly

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer of the Company

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Empyrean Energy plc

b)

LEI

-

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over ordinary shares of 0.2p each ("Ordinary Shares")

Identification code

GB00B09G2351

b)

Nature of the Transaction

Purchase of options in respect of 63,000,000 Ordinary Shares and subsequent exercise of options in respect of 18,000,000 Ordinary Shares at 0.2p per Ordinary Share.

c)

Price(s) and volume(s)

Price

Volume

AU$275,000 (aggregate) (equivalent to approximately £171,000)

Options in respect of 63,000,000 Ordinary Shares with an exercise price of 0.2p to 4.1p per Ordinary Share

 Price

Volume

0.2p

18,000,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

13 March 2017

f)

Place of the transaction

London Stock Exchange, AIM (LON:EME)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGMFGFRGNZM
Date   Source Headline
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM
26th Sep 202212:01 pmRNSPosting of Annual Report and Notice of GM
16th Sep 20227:08 amRNSFinal Results
9th Sep 20227:00 amRNSMako Gas Project - Updated Plan of Development
2nd Sep 20229:04 amRNSPosting of Notice of Annual General Meeting
10th Jun 20227:00 amRNSSecond phase of exploration for Topaz Prospect
7th Jun 20227:00 amRNSChange of Registered Office Address
23rd May 20228:40 amRNSHolding(s) in Company
12th May 20224:41 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
10th May 202211:45 amRNSCapital raising, drill analysis & debt restructure
4th May 20227:33 amRNSProposed drilling of Topaz Prospect
27th Apr 20227:00 amRNSJade well reached Total Depth
25th Apr 202211:59 amRNSHolding(s) in Company
21st Apr 20228:37 amRNSExercise of Warrants
19th Apr 20227:00 amRNSBlock 29/11, China - Jade drilling update
13th Apr 20227:43 amRNSDrilling update at Jade prospect
11th Apr 202212:32 pmRNSExercise of Warrants
11th Apr 20227:00 amRNSDrilling commences at Jade prospect
8th Apr 20229:55 amRNSExercise of Warrants
8th Apr 20227:00 amRNSBlock 29/11, China - NH9 rig on Jade location
4th Apr 20227:00 amRNSBlock 29/11, China – NH9 rig to mobilise
30th Mar 20228:16 amRNSBlock 29/11, China - Jade well update
28th Mar 20228:01 amRNSPartial Conversion of Convertible Note
25th Mar 20227:34 amRNSRig Mobilisation and Anticipated Spud Date
16th Mar 20229:52 amRNSPartial Conversion of Convertible Note
11th Mar 20227:42 amRNSBlock 29/11, China – Jade drilling update
10th Mar 20227:00 amRNSEmpyrean moves to SETS trading platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.